marijuana stocks news

Form 8-K for MEDBOX, INC.

31-Oct-2014

Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On October 30, 2014, Matt Feinstein resigned as a director of Medbox, Inc. (the “Company”). Mr. Feinstein will remain an employee of the Company, serving as a Vice President.

SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided “as is” for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

INSYS Therapeutics, Inc. (INSYS) Commences Phase-2 Clinical Trial of Cannabidiol Oral Solution

Blog Exposure – INSYS Commences Phase-2 Clinical Trial of Cannabidiol Oral Solution…

Tilray, Inc. (TLRY) Launches New Medical Cannabis Edibles in Canada

Tilray Launches New Medical Cannabis Edibles in Canada Tilray, Inc. (“Tilray”) (Nasdaq…

Curaleaf Holdings, Inc. (CURLF) Announces Opening of Branded Store in Wells, Main

Curaleaf Announces Opening of Branded Store in Wells, Maine Curaleaf Holdings, Inc.…

GT Biopharma Inc. (GTBP) Announces 50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness

GT Biopharma Inc. (GTBP) (Euronext Paris: GTBP.PA) announced today that the Proof-of-Concept…